7,10,13,16,19-docosapentaenoic acid

7,10,13,16,19-docosapentaenoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1255 references associated with 7,10,13,16,19-docosapentaenoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 7,10,13,16,19-docosapentaenoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7,10,13,16,19-docosapentaenoic acid

MeSH term MeSH ID Detail
Kidney Failure, Chronic D007676 51 associated lipids
Body Weight D001835 333 associated lipids
Heart Failure D006333 36 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Death, Sudden, Cardiac D016757 12 associated lipids
Chromosome Disorders D025063 4 associated lipids
Total 10

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 7,10,13,16,19-docosapentaenoic acid

Download all related citations
Per page 10 20 50 100 | Total 292
Authors Title Published Journal PubMed Link
Assies J et al. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. 2001 Biol. Psychiatry pmid:11257236
Schneider SM et al. Activity of the leukocyte NADPH oxidase in whole neutrophils and cell-free neutrophil preparations stimulated with long-chain polyunsaturated fatty acids. 2001 Inflammation pmid:11293662
Meinelt T et al. Correlation of diets high in n-6 polyunsaturated fatty acids with high growth rate in zebrafish (Danio rerio). 2000 Comp. Med. pmid:10987667
Retterstøl K et al. The pathway from arachidonic to docosapentaenoic acid (20:4n-6 to 22:5n-6) and from eicosapentaenoic to docosahexaenoic acid (20:5n-3 to 22:6n-3) studied in testicular cells from immature rats. 2000 Biochim. Biophys. Acta pmid:10601701
Rissanen T et al. Fish oil-derived fatty acids, docosahexaenoic acid and docosapentaenoic acid, and the risk of acute coronary events: the Kuopio ischaemic heart disease risk factor study. 2000 Circulation pmid:11094031
Ghebremeskel K et al. Maternal diet high in fat reduces docosahexaenoic acid in liver lipids of newborn and sucking rat pups. 1999 Br. J. Nutr. pmid:10615212
Pirich C et al. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. 1999 Thromb. Res. pmid:10588465
Conquer JA et al. Effect of supplementation with dietary seal oil on selected cardiovascular risk factors and hemostatic variables in healthy male subjects. 1999 Thromb. Res. pmid:10588467
Infante JP and Huszagh VA Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids. 1998 FEBS Lett. pmid:9684854
Infante JP and Huszagh VA On the molecular etiology of decreased arachidonic (20:4n-6), docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids in Zellweger syndrome and other peroxisomal disorders. 1997 Mol. Cell. Biochem. pmid:9062899
Campan P et al. Pilot study on n-3 polyunsaturated fatty acids in the treatment of human experimental gingivitis. 1997 J. Clin. Periodontol. pmid:9442428
Mizutani M et al. Omega-3 polyunsaturated fatty acids inhibit migration of human vascular smooth muscle cells in vitro. 1997 Life Sci. pmid:9364203
Mohammed BS et al. Regulation of the biosynthesis of 4,7,10,13,16-docosapentaenoic acid. 1997 Biochem. J. pmid:9291114
Herzberg GR and Skinner C Differential accumulation and release of long-chain n-3 fatty acids from liver, muscle, and adipose tissue triacylglycerols. 1997 Can. J. Physiol. Pharmacol. pmid:9360007
Reece MS et al. Maternal and perinatal long-chain fatty acids: possible roles in preterm birth. 1997 Am. J. Obstet. Gynecol. pmid:9125620
Prisco D et al. Effect of n-3 polyunsaturated fatty acid intake on phospholipid fatty acid composition in plasma and erythrocytes. 1996 Am. J. Clin. Nutr. pmid:8644688
Rotstein NP et al. Active synthesis of C24:5, n-3 fatty acid in retina. 1996 Biochem. J. pmid:8670163
Brossard N et al. Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. 1996 Am. J. Clin. Nutr. pmid:8839503
Pawlosky RJ and Salem N Ethanol exposure causes a decrease in docosahexaenoic acid and an increase in docosapentaenoic acid in feline brains and retinas. 1995 Am. J. Clin. Nutr. pmid:7762532
Leichsenring M et al. Polyunsaturated fatty acids in erythrocyte and plasma lipids of children with severe protein-energy malnutrition. 1995 Acta Paediatr. pmid:7633146